The Termeer Foundation, a nonprofit organization focused on connecting life science innovators and catalyzing the creation of new medicines, has named Tevard CEO and co-founder Daniel Fischer as a member of the Class of 2022 Henri Termeer Fellows.

The Henri Termeer Fellowship honors “emerging leaders within the life science industry who have shown initial promise as company founders, CEOs or heads of life science organizations and are dedicated to developing life-changing treatments for patients,” the foundation said in its announcement.

“This year’s group of Termeer Fellows represents a tremendous group of scientists and business leaders involved in novel work with strong potential impact on medical research, the business of biotech and ultimately those patients who live with a host of unmet medical needs,” said Belinda Termeer, President of The Termeer Foundation.

“Each year the selection of the Termeer Fellows becomes increasingly more competitive and challenging, and this year’s pool of outstanding applicants all have incredible promise of making a meaningful difference in the life science industry,” said Alan Walts, Co-Founder and Member of the Board of Directors, The Termeer Foundation.

In his profile for the fellowship, Fischer cited his greatest accomplishment so far as “bringing together a group of great scientific minds to pioneer a new therapeutic modality to cure rare and severe genetic diseases.”

More information on Fischer and the rest of the newly named fellows is available on the Termeer Foundation website.